glaxo aims profit fall
glaxosmithkline profits fall europe biggest drugmaker recovery
cheap copies drugs paxil wellbutrin weak dollar hit profits global sales firm confident drug pipeline deliver profits failure obesity drug chief executive garnier difficult
afternoon trade london company share price pence garnier company absorbed lost sales generics managing grow business continuing success key products forward performance terms development pipeline progress firm discontinued development experimental treatment obesity disappointing clinical trial glaxo relying treatments conditions cancer diabetes depression allergies lift pace sales growth disappointing
